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ABSTRACT: B lymphocytes from CBA/J mice were stimulated in splenocyte cultures for 72 h with various 
endotoxins. Bisphosphoryl lipid A from Escherichia coli had the highest stimulatory effect followed by 
LPS of Citrobacter freundii and Salmonella minnesota as measured by [3H] thymidine uptake. Gangliosides 
of stimulated B cells (metabolically labeled with D- [ l-14C]galactose and D-[ l-14C]glucosamine) and unlabeled 
gangliosides from resting B cells (prepared from spleens without stimulus) were analyzed by high-performance 
TLC, DEAE anion-exchange HPLC, and immunostaining procedures. Contents of ganglioside-derived 
sialic acids, quantified by HPLC as their fluorescent derivatives, decreased from stimulated to resident B 
lymphocytes in the following order: LPS S. minnesota > LPS C. freundii > bisphosphoryl lipid A E .  coli 
> resting B cells. Gangliosides of resting B cells contained more N-glycolyl- than N-acetylneuraminic acid, 
whereas inverse ratios were found in activated cells, indicating a shift from N-glycolyl- to N-acetylneuraminic 
acid due to stimulation. Furthermore, a higher disialoganglioside content was characteristic for activated 
B cells. Fast atom bombardment mass spectrometry was performed with permethylated mono- and 
disialoganglioside fractions of LPS S. minnesota and LPS C. freundii stimulated B cells. Major gangliosides 
were GMla and G D ~ ~  beside minute amounts of GDlb. The structural heterogeneity in the gangliosides was 
caused by (a) N-substitution of the sialic acids with either acetyl or glycolyl groups, (b) variation in the 
long-chain base (sphingosine, sphinganine), and (c) substitution of the ceramide moiety by fatty acids of 
different chain length and degree of unsaturation (C16:0, C24:0,24:~). In summary, these findings indicate the 
predominance of the GMla pathway in murine B lymphocytes whereas GMlb-type gangliosides are preferentially 
expressed in T lymphocytes as well as macrophages. 
Gangliosides are a diverse group of glycosphingolipids 
(GSLs)' composed of long-chain base, fatty acid, and 
carbohydrate moieties (Hakomori, 198 1). Structures and 
functions have been widely reviewed (Stults et al., 1989; 
Thompson & Tillack, 1985; Zeller & Marchase, 1992). 
Gangliosides are characterized by the presence of one or more 
sialic acid units in the oligosaccharide chain. The parent 
compounds are N-acetylneuraminic acid (Neu5NAc) and 
N-glycolylneuraminic acid (NeuSNGc), which play crucial 
roles in various biological functions (Schauer, 1985, 1988). 
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Abbreviations: AcP LipA, bisphosphoryl lipid A, FAB-MS, fast 
atom bombardment mass spectrometry; GSL(s), glycosphingolipid(s); 
HPLC, high-performance liquid chromatography; HPTLC, high-per- 
formance thin-layer chromatography; NeuSNAc, N-acetylneuraminic 
acid; NeuSNGc, N-glycolylneuraminic acid; LPS, lipopolysaccharide; 
PBS, phosphate-buffered saline; PHA, phytohemagglutinin; SBA, soybean 
agglutinin. The designation of the following glycosphingolipids follows 
the IUPAC-IUB recommendations (1977) and the ganglioside nomen- 
clature system of Svennerholm (1963): Gangliotetraosylceramide or 
GgOsedCer, Galfll-3GalNAcfl1-4Ga1j31-4Glcfll-1 Cer; G M ~ ~ ,  I13Neu- 
5NAc-GgOsqCer; G ~ l b  IV3Neu5NAc-Gg~Cer; GDI~ .  IV3Neu5NAc,- 
I13Neu5NAc-GgOse4Cer; G D I ~  I13(Neu5NAc)z-GgOse4Cer; GDI,, IV3- 
Neu5NAc,II16Neu5NAc-GgOse4Cer; GTlb, IV3Neu5NAc,I13(Neu- 
SNAc)z-GgOse&r; G Q I ~  V3(Neu5NAc)~,I13(Neu5NAc)rGgOse4Cer. 
0006-2960/93/0432- 12685$04.00/0 
Because gangliosides are primarily localized in the outer leaflet 
of plasma membranes, they are ideally positioned to interact 
with neighboring cells and components of the extracellular 
milieu. 
In the past, GSLs of murine immune cells (Stein et al., 
1978) have been analyzed with the aim of detecting GSLs 
which might be specifically expressed by, e.g., thymocytes 
(Schwarting & Gajewski, 1983), macrophages (Mercurio et 
al., 1984; Yohe et al., 1985; Yohe & Ryan, 1986) and B 
lymphocytes (Yohe et al., 1990; Chaby et al., 1986). Gan- 
GD~,) were found to be expressed by Con A stimulated murine 
T lymphocytes (Miithing et al., 1987, 1989). Since GMlb- 
type gangliosides were also detected in GSL extracts of mouse 
spleen (Nakamura et al., 1984,1987) and in lymphoid tumor 
cell lines (Murayama et al., 1986; Bartoszewicz et al., 1986; 
Rokukawa et al., 1988; Lafertk et al., 1987; Miithing et al., 
1991), these structures were suggested to be T cell specific. 
Recent reports of Yohe et al. (1991, 1992) indicated the 
presence of GM1b in stimulated murine macrophages as well 
as the expression of GMlb-type gangliosides in a murine 
myelomonocytic leukemic cell line, respectively. However, 
this ganglioside pathway appears to be dominant in murine 
immune cells. Reports of several groups have indicated 
involvement of gangliosides in immunological functions 
(Marcus, 1982), e.g., as receptors for immunoregulatory agents 
(Liu et al., 1982; Parker et al., 1984) and as compounds with 
immunoregulatory potency (Ladisch et al., 1983; Bergelson 
et al., 1989). Furthermore, GSLs may play a role in immune 
cell circulation and/or localization in lymphoid organs. Since 
no detailed structural data of B lymphocyte gangliosides have 
gliosides of the GMlb pathway (i.e., GMib, GalNAc-GMlb, and 
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been available yet, we spent our efforts in extending the 
previous work in further structure elucidation of gangliosides 
from murine B cells. For this purpose, B lymphocytes were 
stimulated with various endotoxins in splenocyte cultures, and 
qualitative as well as quantitative differences in ganglioside 
expression of stimulated and resident B cells were investigated. 
Preliminary results have been reported (Portner et al., 1992). 
MATERIALS AND METHODS 
Animals. Female CBA/J inbred mice 6-8 weeks of age 
were purchased from GI. Bomholtgard Ltd. (Ry, Denmark) 
and from the Zentralinstitut fur Versuchstierzucht (Hannover, 
Germany). 
Spleen Cell Cultures. Mice splenocytes were prepared as 
described previously (Muthing et al., 1987), and leukocytes 
were counted in Turk's solution with a hemocytometer. B 
lymphocytes were specifically stimulated in splenocyte cultures 
with various mitogenic endotoxins (see below) in DMEM 
containing penicillin G (65 pg/mL), streptomycin (100 pg/ 
mL), and 44 mM NaHC03, supplemented with 5% (v/v) 
heat-inactivated FCS (Boehringer, Mannheim, Germany). 
The cells were cultured in a humidified atmosphere of 10% 
CO1 in air at 37 OC. 
Mitogens. LPS from Salmonella minnesota was purchased 
from Sigma (Deisenhofen, Germany). LPS from Citrobacter 
freundii was extracted with phenol/water and purified by 
reextraction with phenol/chloroform/petroleum ether, ul- 
tracentrifugation, electrodialysis, and precipitation with di- 
valent cations as described in detail elsewhere (Galanos et al., 
1979). Bisphosphoryl lipid A (AcP Lip A) was prepared from 
LPS of the Re-mutant strain F515 of Escherichia coli by 
hydrolysis in acetate buffer as described elsewhere (Brade & 
Brade, 1985). 
Determination of DNA Synthesis. The mitogenic response 
of endotoxins was obtained in microtiter plates (NUNC, 
Wiesbaden, Germany). Mitogens were added to 1 X 106 
splenocytes to give a final total volumeof 0.2 mL. Splenocytes 
were incubated with various concentrations of endotoxins and 
cultivated from 24 h up to 98 h to determine the optimal 
mitogenic response of the respective endotoxins. Twelve hours 
before harvest, [3H] thymidine (2 Ci/mmol or 74 GBq/mmol; 
Amersham Buchler, Braunschweig, Germany) at a final 
concentration of 2 pCi/mL was added to the cultures. Cells 
were collected in a 12-well cell harvester (Skatron, Tranby, 
Norway) by pouring them onto glass fiber filters (Skatron, 
I-pm pore diameter), washed successively with PBS, 10% 
trichloroacetic acid, and 95% ethanol, and dried. The filters 
were placed into scintillation vials, and 3 mL of Aqualuma 
plus (Baker, Gross-Gerau, Germany) was added to each vial. 
The samples were counted 1 h later in a Tri-Carb 1900 CA 
liquid scintillation spectrometer (Packard Instrument Co., 
Downers Grove, IL). The data were presented as counts per 
minute (cpm) per lo6 living leukocytes originally placed in 
culture. 
B Cell Preparation for Ganglioside Isolation. Splenocytes 
were stimulated for 72 h with LPS from S. minnesota (50 
pg/mL), LPS from C. freundii (3.2 pg/mL), and AcP Lip 
A from E.  coli (1.6 pg/mL) in DMEM as described above. 
The cells were cultured in 90-mL volumes in tissue culture 
flasks (NUNC) at a concentration of 5 X lo6 cells/mL. 
Stimulated as well as resting B cells (splenocyte preparations 
without stimulus) were isolated by agglutination with soybean 
agglutinin (SBA, Medac, Hamburg, Germany) according to 
Reisner et al. (1976) with minor modifications. About 3.2 X 
IO9 splenocytes were washed with 20 mL of PBS containing 
1 mg/mL glucose and incubated with 8 mL of SBA in PBS 
Portner et al. 
(1 mg/mL, 4 x 108 cells/mL) for 10 min at room temperature. 
Two-milliliter aliquots were then gently layered on top of 4 
mL of FCS/PBS ( l / l ,  v/v). After 15 min at room tem- 
perature, agglutinated B lymphocytes (bottom fraction) were 
suspended in 4 mL of 0.2 M D-galactose in PBS, incubated 
for 10 min at room temperature, and washed twice with PBS. 
Viability was determined by trypan blue exclusion with a 
hemocytometer. Finally, the cells were suspended in chlo- 
roform/methanol (2/1, V/V) and stored at -20 OC. 
Metabolic Labeling of B Cell Gangliosides. Stimulated B 
lymphocytes were labeled for 72 h in splenic cultures (see 
above) with 0.5 pCi/mL (18.5 kBq/mL) ~ - [ l - l ~ C ] g l u -  
cosamine hydrochloride (54 mCi/mmol or 2 GBq/mmol) and 
0.5 pCi/mL (18.5 kBq/mL) D-[l-14C]galactose (57 mCi/ 
mmol or 2.1 1 GBq/mmol; Amersham Buchler). B lympho- 
cytes were separated by SBA agglutination and gravity 
sedimentation as described above. 
Isolation of Gangliosides. B cell gangliosides were isolated 
as described for mouse T lymphocytes by Miithing et al. (1 987) 
and were further purified after the anion-exchange chroma- 
tography step on a small Iatrobeads column (6RS-8060; 
Macherey-Nagel, Diiren, Germany) as described by Ueno et 
al. (1978). 
High-Performance Liquid Chromatography. Whole gan- 
gliosides were fractionated by anion-exchange HPLC on a 
column of Fractogel DEAE 65043 (1 .O cm X 15 cm, 25-40- 
pm average particle size; E. Merck, Darmstadt, Germany). 
The HPLC system (Gilson Abimed, Langenfeld, Germany) 
consisted of three M 303 pumps, a high-pressure M 8 1 1 mixer, 
and a computer-control module. The column was rinsed with 
3 column volumes of chloroform/methanol/water (30/60/8 
by volume). The whole ganglioside fraction was applied, and 
after being rinsed with 3 column volumes of the same solvent 
and methanol, gangliosides were eluted with a programmed 
gradient up to 0.1 M methanolic ammonium acetate. The 
flow rate was 0.5 mL/min, and fractions were collected every 
4 min (2-mL fractions). Aliquots of each fraction were 
transferred to scintillation vials. After evaporation of the 
organic solvent, 3 mL of Lipoluma (Baker) was added to each 
vial, and the radioactivity was determined as described above. 
Determination of Sialic Acids. Neu5NAc and NeuSNGc 
of gangliosides were identified and quantified as their 
fluorescent derivatives by HPLC essentially as described by 
Hara et al. (1987). Gangliosides were dissolved in 0.2 mL of 
25 mM H2S04 and heated for 1.5 h at 80 OC. Released sialic 
acids were converted with 1,2-diamin0-4,5-methylenedioxy- 
benzene (DMB, Sigma) into fluorescent derivatives. DMB 
solution (7.0 mM) was prepared by dissolving DMB dihy- 
drochloride in water containing 1 M P-mercaptoethanol and 
18 mM sodium hydrosulfite (Hara et al., 1987); 200 pL of 
the DMB solution was added to the cooled hydrolysate, and 
the mixture was heated at 60 OC for 2.5 h in the dark. The 
reaction was stopped in ice/water, and aliquots were used for 
HPLC analysis. Reference Neu5NAc was purchased from 
Biomol (Hamburg, Germany) and Neu5NGc from Sigma. 
HPLC was carried out with a Kontron D 450 system consisting 
of two HPLC type 420 pumps, a type 460 autosampler, an 
SFM 25 fluorometer, and a MT 450 data system (Buntemeyer 
et al., 1991). Isocratic HPLC was performed using an RP18 
column (250 mm X 4.6 mm, ODS 5 pm; Beckman, Munchen, 
Germany) as the stationary phase and acetonitrile/methanol/ 
water (8/8/84 by volume) as the mobile phase. The flow rate 
was 1.2 mL/min. It was operated at an excitation wavelength 
of 373 nm and an emission wavelength >448 nm. 
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Murine B Cell Gangliosides 
Reference Gangliosides. Human brain gangliosides were 
purchased from Supelco (Bellefonte, PA). Reference gan- 
gliosides from Con A stimulated murine T lymphocytes were 
isolated as described by Miithing et al. (1987) and are listed 
in Table 11. 
Thin- Layer Chromatography. Silica gel precoated high- 
performance thin-layer chromatography plates (HPTLC 
plates, size 10 cm X 10 cm, thickness 0.24 mm; E. Merck) 
were used. Gangliosides were separated in chloroform/ 
methanol/water (120/85/20 by volume) containing 2 mM 
CaC12 and were visualized by resorcinol (Svennerholm, 1957). 
14C-Labeled gangliosides were located by autoradiography 
on HyperfilmJH (Amersham Buchler). 
HPTLC Immunostaining Assay with Cholera Toxin B 
Subunit (Choleragenoid). The HPTLC binding method using 
cholera toxin B subunit for specific detection of Ghlla has 
been developed by Magnani et al. (1980). We modified the 
described method as follows. Gangliosides were chromato- 
graphed on HPTLC plates, and the silica gel was fixed with 
poly(isobuty1 methacrylate). The plate was incubated with 
choleragenoid (Sigma, no. C-7771, 250 ng/mL) in PBS/I% 
(w/v) BSA (solution A) for 2 h at room temperature. Goat 
anti-choleragenoid antiserum (Calbiochem, no. 227040, 
Frankfurt, Germany; 1:lOOO in solution A) and alkaline 
phosphatase conjugated rabbit anti-goat IgG (Dianova, 
Hamburg, Germany; 1:lOOO in solution A) were used for the 
immunostaining procedure (1 h at room temperature). 
Alkaline phosphatase activity was detected with 5-bromo-4- 
chloro-3 indolyl phosphateas described (Miithing & Miihlradt, 
1988). 
To reveal the presence of gangliosides with a G M ~ ~  core, 
i.e., GDla, GDlb, GTlb, and GQlb, neuraminidase is employed 
to convert these gangliosides to Ghlla prior to treatment with 
choleragenoid. Silica gel fixed plates were incubated with 50 
milliunits/mL V. cholerae neuraminidase (Behring, Marburg, 
Germany) for 18 h a t  37 OC in 0.05 M sodium acetate/9 mM 
CaC12, pH 5 .5 .  The subsequent immunostaining assay with 
choleragenoid was performed as described above. The 
technique has been originally developed by Wu and Ledeen 
(1988). 
Detection of Gangliosides of the GMib Type on HPTLC 
Plates. Terminally sialylated gangliosides with a GgOsed- 
Cer backbone (GMlb, GD~,) were detected as described 
(Miithing & Miihlradt, 1988). Briefly, gangliosides were 
chromatographed on HPTLC plates. After silica gel fixation, 
the plates were incubated with 5 milliunits/mL V. cholerae 
neuraminidase for 2 h at room temperature in the buffer 
described above. Polyclonal anti-GgOse4Cer antiserum (1 : 
1000) and alkaline phosphatase conjugated goat anti-rabbit 
IgG antiserum (1: 1000) were used for the immunostaining 
procedure. Bound antibodies were visualized with 5-bromo- 
4-chloro-3-indolyl phosphate (Miithing et al., 1991; Miithing 
& Muhlradt, 1988). 
The overlay assay for detection of GalNAC-GMlb with a 
highly specific antiserum has been recently described by 
Miithing et al. (1991). 
Mass Spectrometric Analysis of Gangliosides. The mono- 
and disialoganglioside fractions, obtained from resting and 
from stimulated murine B lymphocytes, were structurally 
characterized by positive (permethylated fractions) ion mode 
FAB-MS as previously reported (Peter-KataliniE & Egge, 
1990). The permethylation was carried out as described by 
Ciucanu and Kerek (1984). Permethylated gangliosides were 
separated from reagents by exhaustive extraction with chlo- 
roform and chromatographed on a 1 cm X 23 cm Sephadex 
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FIGURE 1: [3H]Thymidine incorporation into endotoxin-stimulated 
spleen lymphocytes. lo6 leukocytes/0.2 mL were stimulated for 72 
h with various concentrations of endotoxins. Twelve hours before 
harvesting, the cultures were pulsed with 2 pCi/mL [3H]thymidine. 
Each point represents the mean of duplicate cultures. 
LH-20 column (Pharmacia Fine Chemicals, Freiburg, Ger- 
many) with chloroform/methanol (1 / 1, by volume) as eluent. 
Final purification was performed on a small Iatrobeads column 
(0.5 cm X 5 cm, Iatrobeads 6RS-8060) by elution with 
chloroform, chloroform/methanol(98/2, v/v, 95/5, v/v, and 
95/ 10, v/v), and chloroform/methanol/water (75/24/4, V/V/ 
v). Permethylated gangliosides eluted in the last two fractions. 
Fast atom bombardment mass spectrometry (FAB-MS) 
was performed on a ZAB H F  mass spectrometer (VG 
Analytical, Manchester, Great Britain). The mass spectra 
were acquired as single scans in the upscan mode on an AMD 
DPlO data system fitted with SAM I1 (KWS) hardware and 
SUSY software (AMD Intectra, Beckeln, Germany). 
RESULTS 
Mitogenic Responses of B Lymphocytes to Endotoxins. 
Certain mitogens such as PHA and Con A stimulate T cells 
whereas LPSs stimulate B lymphocytes (Anderson et al., 
1972; DeFranco, 1987). LPSs as well as lipid A, the endotoxic 
center of bacterial LPS, elicit a variety of physiological 
responses in mice (Rietschel et al., 1991). Mitogenic responses 
of B lymphocytes are generally measured by the uptake of 
[3H]thymidine. In order to determine the responses to 
endotoxins from different bacterial sources, murine B lym- 
phocytes were stimulated in splenocyte cultures with LPSs 
from S .  minnesota and C.  freundii and AcP Lip A from E.  
coli. Spleen cells were incubated with various concentrations 
of endotoxins; 72 h was found to induce optimal B cell 
mitogenesis as measured by [3H]thymidine uptake (see 
Materials and Methods). A comparison of the mitogenic 
responses of B lymphocytes to LPSs from S .  minnesota and 
C.  freundii and to AcP Lip A from E .  coli is shown in Figure 
1. The endotoxins produced B cell activation over a wide 
range of concentrations. AcP Lip A had the highest stim- 
ulatory effect at a concentration of 1.6 pg/mL compared to 
optimal LPS doses of C.  freundii (3.2 pg/mL) and S .  
minnesota (50 pg/mL). To analyze the ganglioside expression 
of resident and endotoxin-stimulated B lymphocytes, these 
optimal LPS doses were used for B cell production followed 
by ganglioside isolation (see below). 
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Table I: B Cell Yields and Parameters of B Cell Preparations from Endotoxin-Stimulated and Resident Splenocytes 
stimulus concn total B cell yieldb [3H] thymidine viabili t yd 
endotoxin (pg/mL) leukocytes" (cells/% of leukocytes) uptakeC (cpm) 
LPS S. minnesota 50 6.1 x 109 1.2 x 109/20% 
LPS C. freundii 3.2 6.9 x 109 1.3 X 109/19% 
AcP Lip A E. coli 1.6 7.2 x 109 3.1 X 109/42% 
e 5.3 x 109 2.2 X 109/41% 
13100 82 
15900 73 
27400 89 
82 
0 104 mice spleens were prepared, respectively. Obtained by SBA agglutination. 72-h stimulation of lo6 leukocytes. Determined by trypan blue 
exclusion. e Without stimulus. 
Table 11: Structures of Gangliosides from Con A Stimulated Mouse Splenic T Lymphocytes" 
ganglioside fatty acid 
fraction component structure symbol 
I 
I1 
I11 
IV 
V 
VI 
c241 
Cl60 
c240,  c241 
c24:0, c241 
c 16:O 
c16:O 
c 2 4 0  
C160 
c 2 4 0 ,  c241 
c16:O 
IV3Neu5NAc-GgOse4Cer 
IV3Neu5NAc-GgOse4Cer 
IVNeuSNGc-GgOse4Cer 
IVNeuSNAc-GgOsesCer 
IVNeu SNGc-GgOsesCer 
IVNeuSN Ac-GgOsesCer 
IVNeuSNGc-GgOsesCer 
IVNeuSNGc-GgOsesCer 
IVNeuSNAc,IIINeuSNAc-GgOse4Cer 
IVNeu5NAc,IIINeuSNAc-GgOse~Cer 
GMib (NeuSNAc) 
GMib (NeuSNAc) 
GMib (NeuSNGc) 
GMib (NeuSNGc) 
GalNAc-GMlb (NeuSNAc) 
GalNAc-GMlb (NeuSNAc) 
GalNAc-GMlb (NeuSNGc) 
GalNAc-GMlb (NeuSNGc) 
G D ~ ~  (NeuSNAc, NeuSNAc) 
G D ~ ~  (NeuSNAc, NeuSNAc) 
a Data drawn from Miithing et al. (1987, 1989). 
B Cell Production. The approach for the separation of B 
lymphocytes from splenocyte cultures is based on differential 
agglutinability of leukocytes with lectins. Endotoxin-stim- 
ulated as well as resident B lymphocytes were agglutinated 
by soybean agglutinin (SBA) from Glycine max and separated 
by gravity sedimentation according to Reisner et al. (1976). 
B cell yields and parameters of the B cell preparation are 
summarized in Table I. [ 3H] Thymidine uptake correlated 
with B cell yields obtained by the different endotoxins used 
in this study. Stimulation by LPS of S .  minnesota (SO pg/ 
mL) gave 20%, LPS of C. freundii (3.2 pg/mL) 19%, and 
AcP Lip A (1.6 pg/mL) 42% agglutinated B lymphocytes 
from total leukocytes compared to 4 1% resting B cells prepared 
from mouse spleen without stimulus (see Table I). 
Metabolically Labeled Gangliosides from Endotoxin- 
Stimulated B Lymphocytes. Significant differences between 
the ganglioside patterns of Con A stimulated T cells and LPS- 
stimulated B cells have been reported by Rosenfelder et al. 
(1979). Structural characterizations have shown the con- 
siderable heterogeneity of gangliosides from Con A stimulated 
T lymphocytes (Miithing et al., 1987,1989). The main com- 
ponents found in T cells were IVNeuSNAc/NeuSNGc- 
GgOse4Cer (GMlb), IVNeu5NAc/Neu5NGc-GgOse~Cer 
(GalNAc-GMlb), and IVNeu5NAc,IIINeu5NAc-GgOse~Cer 
( G D ~ ~ ) .  The reference gangliosides from T cells are listed in 
Table 11. 
Metabolically labeled gangliosides from stimulated B and 
T cells are given in Figure 2. Whereas the autoradiography 
of gangliosides from T cells shows a continuum of bands on 
the HPTLC plate (Figure 2, lane a, fractions I-VI), the 
ganglioside patterns of endotoxin-stimulated B cells are 
characterized by two clusters, e.g., S .  minnesota (Figure 2, 
lane b). Gangliosides of the upper cluster chromatographed 
analogously to GMla, and gangliosides of the lower cluster 
showed chromatographic behavior like GDla of reference 
gangliosides from human brain. Similar ganglioside patterns 
of B cells were obtained by the three different endotoxins used 
in our experiments. Slight differences due to some faint 
additional bands superior to the uGMla cluster" were observed 
in the ganglioside fractions of the LPS-stimulated B cells 
compared to AcP Lip A stimulated B cells (see below). Since 
a b c  
FIGURE 2: Autoradiography of 14C-labeled gangliosides from Con 
A stimulated T lymphocytes (lane a) and LPS S. minnesota (lane 
b) stimulated B lymphocytes. 1000 cpm each were applied to the 
HPTLC plate and chromatographed. The exposure time was 360 
h. Ten micrograms of human brain gangliosides (lane c)  was stained 
with resorcinol. T cell gangliosides of bands I-VI are listed in Table 
11. 
chromatographic data are not structurally definitive, we 
further characterized the gangliosides by immunological 
methods (overlay technique), anion-exchange HPLC, and fast 
atom bombardment mass spectrometry as demonstrated in 
the following sections. 
Detection of Gangliosides with a G , U ~ ~  Core. GMla can be 
made visible on the HPTLC plate with choleragenoid using 
the well-working overlay technique. The gangliosides GDla, 
GDlb, GTlb, and GQlb can be detected by conversion with V. 
cholerae neuraminidase to GMla prior to treatment with 
choleragenoid according to Wu and Ledeen (1988). The 
suitability of this highly specific overlay assay is demonstrated 
in Figure 3A using a reference ganglioside mixture from human 
brain containing the mentioned GMla-type gangliosides. GM1a 
was immunostained by choleragenoid without neuraminidase 
treatment (Figure 3A, lane a) and the higher sialylated 
gangliosides with GMla backbone with preceding neuramini- 
dase treatment of the plate (Figure 3A, lane b). Gangliosides 
GMla, GDla, and GTlb were identified in all B cell ganglioside 
fractions by "in situ" staining with choleragenoid. As shown 
in Figure 3B, 1 X lo6 resting B cells produced three well- 
detectable GMla and two GDla immunostained bands, repre- 
senting the main B cell gangliosides. One weak GDlb and 
GTlb band each was detected by usage of this sensitive assay. 
Resting as well as stimulated B cells showed similar overlay 
patterns. Gangliosides from 5 X lo5  AcP Lip A E. coli 
GMla 
GDla 
- GDlb 
GTlb  
D
ow
nl
oa
de
d 
by
 B
IE
LE
FE
LD
 L
IB
RA
RI
ES
 o
n 
Ju
ly
 3
1,
 2
00
9
Pu
bl
ish
ed
 o
n 
M
ay
 1
, 2
00
2 
on
 h
ttp
://
pu
bs
.a
cs
.o
rg
 | d
oi:
 10
.10
21/
bi0
021
0a0
18
Murine B Cell Gangliosides Biochemistry, Vol. 32, No. 47, 1993 12689 
A 
GMla 
GDla 
GQ1 b a b  
B 
J GMla 
GDla 
- 7 GDlb 
~ GTlb 
a b  
FIGURE 3: Detection of GM1,-type gangliosides in resting murine B 
lymphocytes. Fifty nanograms of reference gangliosides from human 
brain (A) and ganglioside aliquots corresponding to lo6 resting B 
lymphocytes (B) were chromatographed and immunostained with 
choleragenoid without (lanes a) and after V. cholerae neuraminidase 
treatment (lanes b). The positions of human brain gangliosides are 
marked at  the margins. 
A B 
GMla, 
GD la  
GDlb - - GTlb 
a b  
I 
II k 
I l l  z 
IV - 
V' 
VI 
-*.ai, 
a b  
FIGURE 4: HPTLC immunostaining of gangliosides from murine B 
lymphocytes stimulated with AcP Lip A from E. coli. (A) 1000 cpm 
of I4C-labeled gangliosides from 5 X lo5 stimulated B lymphocytes 
were chromatographed. Lane a, autoradiography, exposure time 
312 h; lane b, immunostaining with choleragenoid after V. cholerae 
neuraminidase treatment of the same chromatogram. The positions 
of human brain gangliosides are marked at  the margin. (B) 
Gangliosides of 2 X lo6 Con A stimulated T cells (lane a, positive 
control) and 2 X lo6 AcP Lip A stimulated B cells (lane b) were 
chromatographed, and the plates were overlayed with V. cholerae 
neuraminidase. GgOse4Cer bands were detected with specific 
antibodies. T cell gangliosides of bands I-VI are marked at  the 
margin and are listed in Table 11. 
stimulated B cells gave strong GMla and G D ~ ~  bands and sparse 
GDlb and GTlb bands (Figure 4A, lane b). The corresponding 
autoradiography indicated congruency of metabolically labeled 
and immunostained gangliosides (Figure 4A, lane a). Higher 
sensitivity of the immunostaining procedure traced out weak 
GDlb and GTlb bands, which became visible in the autora- 
diography by prolonged film exposure (not shown). 
B cell gangliosides were checked for the presence of GM1b- 
type gangliosides by immunostaining with a specific anti- 
GgOse4Cer antibody on HPTLC plates after V. cholerae 
neuraminidase treatment as described by Muthing and 
Muhlradt (1988). GMlb and GD~,, the characteristic gan- 
gliosides of Con A stimulated T cells (Figure 4B, lane a; see 
Table 11), were not detected in the ganglioside fractions of 
resident and stimulated B cells. As an example, the negative 
stain of gangliosides from LPS S .  minnesota stimulated B 
cells is shown in Figure 4B (lane b). Analysis of gangliosides 
of 2 X lo6 T and B cells each showed predominance of the 
pathway in T cells. However, when the plate was 
overloaded with B cell gangliosides (>1 X lo7 cells), trace 
amounts of GMlb and G D ~ ~  were detected in all B cell 
preparations. This fact will be a point of discussion (see below). 
GalNAc-GMlb, highly expressed on Con A stimulated T cells, 
was not expressed by resident and stimulated B lymphocytes. 
All the immunochemical data were confirmed by fast atom 
bombardment mass spectrometry (see below). 
Mono- and Disialogangliosides from B Lymphocytes. B 
cell gangliosides were separated into mono- and disialogan- 
gliosides by anion-exchange HPLC on DEAE-Fractogel with 
500 
400 
300 
200 
100 
0 
0.08 
0.06 
0.04 
0.02 
0.00 
0 10 20 30 40 50 60 
FRACTION NUMBER 
FIGURE 5:  Anion-exchange HPLC elution profile of 14C-labeled 
gangliosides from LPS Cfreundii stimulated B lymphocytes. 34 000 
cpm of labeled gangliosides were applied onto a Fractogel DEAE 
column and eluted with a gradient of ammonium acetate in methanol. 
Two-milliliter fractions were collected every 4 min, and the radio- 
activity of 10% aliquots was determined in a liquid scintillation counter. 
The monosialogangliosides (fractions 2-1 0, pool a) and the disialo- 
gangliosides (fractions 15-22, pool b) were further characterized by 
HPTLC (see insert). 1000 cpm each were chromatographed; exposure 
time 264 h. The positions of human brain gangliosides are marked 
at  the margin. 
gradient elution of ammonium acetate in methanol. As an 
example, the elution profile of 14C-labeled gangliosides from 
LPS C. freundii is shown in Figure 5. Separated mono- and 
disialogangliosides, fractions 2-1 0 (pool a) and fractions 15- 
22 (pool b), respectively, were further analyzed by HPTLC 
(see insert of Figure 5). The monosialoganglioside cluster 
(pool a) and the disialoganglioside cluster (pool b) showed 
chromatographic behavior like human brain GMla and GDla, 
respectively. Ganglioside separation of AcP Lip A E .  coli 
and LPS S .  minnesota stimulated as well as resident B 
lymphocytes gave similar elution profiles (not shown); elution 
of unlabeled gangliosides from resident B cells was monitored 
by determining the sialic acid content of each fraction. The 
total content of 14C-labeled gangliosides corresponding to 1 O6 
stimulated B cells and mono/disialoganglioside ratios are 
depicted in Figure 6. The highest amounts of 14C-labeled 
gangliosides were raised by stimulation with LPS S.  minnesota 
(A) followed by LPS C. freundii (B) and AcP Lip A E .  coli 
(C) containing 5876, 6696, and 57% monosialogangliosides, 
respectively . 
Sialic Acid Profiles. Sialic acids of whole ganglioside 
fractions from stimulated T and B lymphocytes and resting 
B cells were identified and quantified by HPLC as their 
fluorescent DMB derivatives. Stimulated T cells expressed 
the highest amounts of GSL-bound sialic acids compared to 
B cells (see Figure 7). Sialic acid content decreased from 
stimulated to resident B lymphocytes in the following order: 
LPS S.  minnesota > LPS C. freundii > AcP Lip A E.  coli 
> resting B cells. 
Distinct sialic acid profiles were obtained from mono- and 
disialogangliosides of resting and stimulated B cells. Both 
ganglioside fractions of resident B cells are characterized by 
higher Neu5NGc content (Figure 8B) whereas inverse ratios 
of sialic acids were detected in all fractions from stimulated 
B cells, e.g., AcP Lip A E .  coli stimulus (Figure 8A). Fur- 
thermore, in all cases, sialic acid contents (NeuSNAc plus 
Neu5NGc) were higher in mono- than in disialoganglioside 
fractions (see Table 111). From data of sialic acid concen- 
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' l o o  1 A - 1000 
Y MONOS1 ALOGANGLIOSIDES 
DlSlALOGANGLlOSlDES 0 
m BOO 4 i 1 
100% 30% 14% 
FIGURE 6: Distribution of 14C-labeled mono- and disialogangliosides 
within whole ganglioside fractions of lo6 B lymphocytes stimulated 
with LPS S .  minnesota (A), LPS C. freundii (B), and AcP Lip A 
E. coli (C). Total amounts of I4C-labeled gangliosides are given at 
the bottom of the columns. I4C label raised by LPS S .  minnesota 
was set to 100%. 
140 
0 Neu5NGc 
W Neu5NAc 
I 0 
A B C  D E 
FIGURE7: Content of NeuSNAc and Neu5NGc in wholeganglioside 
fractions of lo6 cells each Con A stimulated T lymphocytes (A), B 
lymphocytes stimulated with LPS S.  minnesota (B), LPS C. freundii 
(C), AcP Lip A E. coli (D), and resting B cells (E). NeuSNAc and 
NeuSNGc, released by acid hydrolysis of gangliosides, were identified 
and quantified as their fluorescent DMB derivatives by isocratic 
HPLC using an RPlg column as the stationary phase and acetonitrile/ 
methanol/water (8/8/84 by volume) as the mobile phase. 
trations, mono- and disialoganglioside contents were evaluated. 
The quotients of mono-/disiaIoganglioside concentrations (see 
Table 111) indicated an increase of amounts of disialogan- 
gliosides in activated B cells (mono-/disialogangliosides = 
2.3) compared to resting B cells (mono-/disialogangliosides - 4.8). The same shift in ganglioside sialylation has been 
described in resident and Con A stimulated T lymphocytes 
(Muthing et al., 1989). 
FAB Mass Spectrometry. Due to limited quantities of 
material, further structural characterization of B cell gan- 
gliosides by FAB mass spectrometry was performed with the 
entire mono- and disialoganglioside fractions obtained by 
anion-exchange HPLC (see above). Due to the minute 
amounts of gangliosides obtained from resting and AcP Lip 
A E. colistimulated B lymphocytes, structural characterization 
by FAB-MS gave no reproducible results. However, the 
compounds of the mono- and disialoganglioside fractions from 
LPS S. minnesota and LPS C. freundii stimulated B cells 
could be clearly deduced from their molecular and specific 
fragment ions. Structural features of NeuSNAcvs NeuSNGc, 
120 I 
L 
1 
5 I +I s n  . . . . . . .  . . . . . .  
0 2 4 6  8 l O U ' l O  2 4 6  8 1 0 P  
TIME [ d l  TIME I* 
1 
B 
- 3 1 0  2 4 6  8 1 o ; z  
TIME [ruin] TIME [&I 
FIGURE 8: HPLC elution profiles of fluorescent DMB derivatives 
of sialic acids released from mono- (I) and disialogangliosides (11) 
of AcP Lip A E. coli stimulated (A) and resting B lymphocytes (B). 
Aliquots corresponding to 1.2 X lo7 cells, respectively, were applied 
to the column. NeuSNAc and NeuSNGc were separated by isocratic 
elution with acetonitrile/methanoI/water (8/8/84 by volume) on an 
RPls column. The flow rate was 1.2 mL/min. 
Table 111: Sialic Acid Contents and Ratios of Mono- and 
Disialoganglioside Fractions from Endotoxin-Stimulated and Resting 
B Lymphocytes 
ganglio- 
NeuSNAd Neu5NGd sidesa$ quotient 
ganglio- side 
endotoxin MIDc MIDc M I D  M I D  
LPS S.  minnesota 14.10/10.54 59317.24 20.03J8.89 2.25 
LPS C. freundii 2.4612.18 1.941 1.29 4.4012.04 2.21 
AcP Lip A E. coli 1.4211.49 0.80/0.40 2.2210.95 2.34 
d 0.84/0.40 1.1110.44 2.0110.42 4.79 
'Given in femtomoles per lo6 cells. bEvaluated from sialic acid 
contents. M = monosialoganglioside, D = disialogangliosides. Resting 
B cells without stimulus. 
the site of substitution, and the nature of sugar backbones and 
ceramide moieties were investigated as their permethylated 
derivatives in the positive ion mode. Their structural pa- 
rameters determined from FAB-MS experiments are given in 
Table IV. 
FAB-MS of Monosialogangliosides. In Figure 9A, major 
molecular structures of the Gllla type present in the per- 
methylated monosialoganglioside sample, containing NeuSNAc 
and NeuSNGc sialic acids, and C16:o and C240 fatty acids 
obtained after LPS S. minnesota stimulation of B cells are 
shown. The molecular ions [M + H]+ of G M I ~  (NeuSNAc, 
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Table IV: Structural Compositions of the Major Gangliosides from LPS S. minnesofa and LPS C. freundii Stimulated B Lymphocytes 
Obtained by Positive FAB-MS of Their Permethylated Derivatives 
12691 
[M + H]+of 
permethylated ganglioside fatty acid long-chain base symbol structure 
1798/1800 
1910/1908 
1828/ 1830 
1940/ 1938 
2159/2161 
2269/2211 
2189/2191' 
229912301 
Traces only. 
(2160 
(2140 
Cl60 
sphingosine/sphinganine 
,241 sphingosine 
sphingosine/sphinganine 
c140,241 sphingosine 
C160 sphingosine/sphinganine 
c240,241 sphingosine 
Cl6:O sphingosine/sphinganine 
c240.241 sphingosine 
IINeuSN Ac-GgOse4Cer 
IINeuSNAc-GgOse&er 
IINeuSNGc-GgOse4Cer 
IINeuSNGc-GgOse4Cer 
IVNeuSNAc,IINeu5NAc-GgOse~Cer 
IVNeuSNAc,IINeuSNAc-GgOserCer 
IVNeuSNGcJINeuSNAc-GgOsedCer 
IVNeuSNGc,IINeuSNAc-GaOse~Cer 
FIGURE 9: Positive-ion FAB-MS and fragmentation schemes of the 
monosialoganglioside fraction of LPS S. minnesota (A) and the 
disialoganglioside fraction of LPS C. freundii (B) stimulated B 
lymphocytes. In (A), the fragmentation schemes only of C1a.o fatfy 
acid containing species are presented. The gangliosides are listed in 
Table IV. TG = thioglycerol. 
C16:O) and GMla (NeuSNGc, Cl6:o) appeared at m / z  = 1798 
and 1828, respectively, and [M + H]+ of GM1a (NeuSNAc, 
(2240) and GMla (NeuSNGc, C24:o) at m l z  = 1910 and 1940, 
respectively. The subsets of sphinganine-derived G M ~ ~  were 
present mostly in the species containing C16:o fatty acid in the 
ceramide portion, whereas in the C240-containing species also 
unsaturatedcomponents ([M + H]+at m l z  = 1800and 1830, 
and m / z  = 1908 and 1938, respectively) were detected. The 
existence of GMla-type gangliosides was deduced from the 
presence of the ion at m / z  = 464 -. 228, [Hexl-3HexNAc]+. 
The ion at m / z  = 825, [NeuSNAc-Hexl-3HexNAc]+, 
characteristic for the G ~ l b  type was present at very low 
intensity, indicating the predominance of the G M ~ ~  type over 
theGMlbtype(ca. 9:1), whichisinagreementwiththeHPTLC 
overlay analysis (see above). 
FAB-MS of Disialogangliosides. Major molecular struc- 
tures in the disialoganglioside fractions belong to the GDla 
series carrying NeuSNAc on the internal galactose and 
NeuSNAc or Neu5NGc units on the terminal galactose as 
shown for LPS C. freundii stimulated B cells in Figure 9B. 
Further heterogeneity arises from the variation in the long- 
chain base and fatty acid in the ceramide portion like in the 
monosialoganglioside fraction (see above). The molecular 
ions [M + H]+Of GDla [NeuSNAcz (C240,241) and NeuSNGc, 
NeuSNAc, (C24:0,241)] appeared at m l z  = 226912271 and 
m / z  = 229912301, respectively. The C24 fatty acid portion 
with and without the double bond is linked to sphingosine, 
whereas the C16:o species of GDla (NeuSNAcz, C16:o) is linked 
to sphingosine and sphinganine long-chain base ([M + H]+ 
at m / z  = 215912161). The predominance of GDla-type over 
GDlb-type gangliosides is documented by the fragment ions 
m / z  = 825 [NeuSNAc-Hexl-3HexNAc]+ and m / z  = 855 
[NeuSNGc-Hexl-3HexNAc]. NeuSNGc was present only 
at the terminal galactose, since no molecular MH+/MNa+ 
ions for NeuSNGc2-GgOse4Cer have been detected. The 
unusual mixed [NeuSNAc-NeuSNGc]+ fragment (Nakamura 
et al., 1991) at m / z  = 767 characteristic for GDlb-type 
ganglioside was of only low intensity, indicating the predom- 
inance of the GDla type as shown by HPTLC overlay analysis 
as well (see above). These results reveal the expression of the 
sphinganine-type long-chain base only in the ceramide species 
containing C16:O fatty acid chain in both mono- and disialo- 
ganglioside fractions. The ratio of sphingosine to sphinganine 
was approximately 514 in the monosialoganglioside and 4/5 
in the disialoganglioside fraction (see Figure 9). No sphin- 
ganine was present in the ceramide portions carrying C24:0,241 
fatty acids. Gangliosides containing saturated long-chain base 
were the major components in LPS CJreundii whereas in 
LPS S. minnesota activated B cells only low amounts of 
sphinganine could be detected. Due to the lack of material 
of isolated gangliosides from resting and AcP Lip A E.  coli 
stimulated B cells, their structures could not be confirmed by 
FAB-MS. However, thin-layer chromatographic and im- 
munological data (see above) suggest the expression of 
gangliosides identical to those found in LPS S. minnesota and 
LPS C. freundii stimulated B lymphocytes. In this context, 
it should be stressed that the overall expression of gangliosides 
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in AcP Lip A E. colistimulated B lymphocytes was particularly 
low whereas the cell growth rate of this subpopulation, as 
monitored by [3H]thymidine incorporation, and B cell yield 
were particularly high (see Table I). 
DISCUSSION 
Expression of G , u ~ ~ -  Type Gangliosides in Murine B 
Lymphocytes. Changes in both the quantity and the structural 
complexity of B cell gangliosides upon stimulation by different 
endotoxins compared to resident cells were studied. Major 
gangliosides detected in all B cell ganglioside fractions were 
GMla and GDla besides minute amounts of GDlb. The structural 
heterogeneity of gangliosides was caused by four factors: (a) 
N-substitution of the sialic acids with either acetyl or glycolyl 
groups; (b) the site of glycosidic linkage by NeuSNAc and/or 
NeuSNGc in disialogangliosides; (c) variation in the long- 
chain base (sphingosine, sphinganine) and (d) fatty acid ( C S ~  
and C16) in the ceramide portion. 
Absence of GMlb-Type Gangliosides in Murine B Lym- 
phocytes. Rosenfelder et al. (1979) first described differing 
ganglioside patterns of metabolically labeled murine T and 
B lymphoblasts. Studies on murine thymus gangliosides by 
Schwarting and Gajewski (1983) indicated the presence of 
GMlb-type gangliosides. In the murine immune system, GMlb 
and GalNAC-GMlb were found in spleen (Nakamura et al., 
1984, 1987), splenic T lymphoblasts (Muthing et al., 1987), 
and thymocytes (Muthing et al., 1989). Increased amounts 
of GalNAc-GMlb were detected in Con A stimulated splenic 
T cells compared to unstimulated thymocytes by Muthing et 
al. (1989). These data have been recently confirmed by 
Horikawa et al. (1991). The uncommon ganglioside GD~,, a 
IIFGalNAc sialylation product of GMlb, was found to be 
characteristic for stimulated T cells (Muthing et al., 1989) 
and has also been detected in murine T helper subpopulations 
(Ebel et al., 1992). Due to the expression of GMlb-type 
structures on lymphoid tumor cell lines (Murayama et al., 
1986; Bartoszewicz et al., 1986; LafertC et al., 1987; Muthing 
et al., 1991), these gangliosides were suggested to be T cell 
specific at this stage of research. The first evidence of GMlb 
expression in murine macrophage came from Saito et al. 
(1980). ThepresenceofGMlbas a major component of murine 
macrophages was clearly demonstrated in the recent work of 
Yohe et al. (1991). In addition to G ~ i b ,  GalNAC-GMlb and 
Gal-GalNAc-GMlb were detected in a murine myelomonocytic 
leukemic cell line with macrophage like properties by the same 
group (Yohe et al., 1992). Therefore, gangliosides of the 
GMlb pathway seem to be dominant and characteristic of 
murine T lymphocytes, macrophages, and related cell lines, 
but the functional importance of these compounds in the 
immune system is not yet known. As shown in this study, 
Gah"c-GM1b was not detected, but small amounts (about 
5%) of GM1b were present in B cell preparations, separated 
by use of soybean agglutinin. Since the agglutinated fraction 
may contain about 5% T lymphocytes (Reisner et al., 1976), 
low amounts of GM1b may be derived from T cells present in 
separated B cell preparations. 
Ganglioside Content of Resting and Stimulated B Lym- 
phocytes. Absolute amounts of gangliosides determined by 
incorporated radioactivity differed depending on the B cell 
stimulus used. Stimulation with LPS S .  minnesota resulted 
in the highest ganglioside label (set to loo%), followed by 
LPS C. freundii and AcP Lip A E.  coli expressing only 30% 
and 14% of theS. minnesota label, respectively. Interestingly, 
metabolical ganglioside and [3H] thymidine label were in- 
versely correlated; Le., AcP Lip A E.  coli raised the highest 
Portner et al. 
[3H] thymidine but lowest ganglioside label whereas LPS S .  
minnesota stimulus led to the highest ganglioside expression 
but induced the lowest DNA synthesis. No significant 
alteration in the mono- to disialoganglioside ratio due to 
stimulation was observed, showing an average amount of about 
60% monosialogangliosides determined by '4C-labeling. Quan- 
titatively, GSL-derived sialic acids correlated with ganglioside 
metabolic radiolabeling. Comparison of GSL-bound sialic 
acids of stimulated T cells and stimulated and resting B cells 
indicated further profound differences in both lymphocyte 
subpopulations. The highest sialic acid content of stimulated 
B cells, represented by LPS S .  minnesota with 38 fmol/106 
cells, corresponds to 130 fmol/ 1 O6 T cells. Differences within 
the B cell subpopulations due to stimulation were obvious 
when ratios of NeuSNAcvs NeuSNGc werecompared. While 
resting B cells express more NeuSNGc- than NeuSNAc- 
substituted gangliosides, inverse ratios were found in the 
ganglioside fractions of stimulated B cells. When mono-/ 
disialoganglioside ratios of resting and stimulated B lym- 
phocytes were compared, increased amounts of disialogan- 
gliosides were expressed in activated B cells. The same shift 
has been observed in resting and Con A stimulated T 
lymphocytes (Miithing et al., 1989). Therefore, the changes 
in sialic acid expression may be a common principle in 
leukocyte stimulation and/or differentiation. 
SUMMARY 
GMla-type gangliosides, i.e., G M ~ ~  and GDla, were found to 
be the main gangliosides in resting and stimulated mouse B 
lymphocytes. Our data show that there are profound dif- 
ferences in the expression of gangliosides in murine leukocytes. 
Whereas T lymphocytes (Miithing et al., 1987) as well as 
macrophages (Yohe et al., 1991) express gangliosides of the 
GMlb pathway, the G M ~ ~  pathway is predominant in B cells. 
It is likely that gangliosides and GSLs in general may play 
a role either in immune cell circulation or in their localization 
in lymphoid organs. 
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